Cite
Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.
MLA
Petursson, Halfdan, et al. “Is the Use of Cholesterol in Mortality Risk Algorithms in Clinical Guidelines Valid? Ten Years Prospective Data from the Norwegian HUNT 2 Study.” Journal of Evaluation in Clinical Practice, vol. 18, no. 1, Feb. 2012, pp. 159–68. EBSCOhost, https://doi.org/10.1111/j.1365-2753.2011.01767.x.
APA
Petursson, H., Sigurdsson, J. A., Bengtsson, C., Nilsen, T. I. L., & Getz, L. (2012). Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study. Journal of Evaluation in Clinical Practice, 18(1), 159–168. https://doi.org/10.1111/j.1365-2753.2011.01767.x
Chicago
Petursson, Halfdan, Johann A. Sigurdsson, Calle Bengtsson, Tom I. L. Nilsen, and Linn Getz. 2012. “Is the Use of Cholesterol in Mortality Risk Algorithms in Clinical Guidelines Valid? Ten Years Prospective Data from the Norwegian HUNT 2 Study.” Journal of Evaluation in Clinical Practice 18 (1): 159–68. doi:10.1111/j.1365-2753.2011.01767.x.